U.S. plastics is a heavyweight: $97.7B in GDP (NAICS 326) in 2023 and employs over 716K people as of July 2025. That scale makes every quality slip, non-compliance, or spec variance expensive—and environmentally costly. Automating Certificates of Analysis (COAs) is no longer back-office hygiene; it’s how resin producers, converters, and brand owners prove compliance, cut waste, and hit sustainability targets. FREDBureau of Labor Statistics
Quality & Safety: COAs verify resin grade, MFI, density, additives, heavy metals, and migration compliance—foundational for FDA 21 CFR Part 177 food-contact applications. Automating intake/validation reduces manual error and speeds release-to-run. eCFRU.S. Food and Drug Administration
Regulatory Proof: COAs (plus attached test reports) provide the evidence trail for PFAS restrictions in packaging and evolving state EPR laws. In audits, “show me the paper” really means “show me the data.” U.S. Food and Drug AdministrationCalRecycle Home Pageepr.sustainablepackaging.org
Food-contact plastics: FDA regulates the substances that can contact food (21 CFR 177). COAs confirm the polymer/additive system used is authorized and within limits. eCFRU.S. Food and Drug Administration
PFAS in packaging: FDA notes that as of Jan 2024 PFAS grease-proofers are no longer being sold into the U.S. market for food contact—brands still need supplier attestations/COAs to enforce this at scale. States are also enacting PFAS bans in packaging. U.S. Food and Drug AdministrationBCLP
EPR & recyclability (California SB 54): Producers must shift packaging to recyclable/compostable formats and hit 30% recycling by 2028, 65% by 2032, with fees tied to design impact. Accurate COA data (resin, additives, colorants) supports recyclability claims and fee calculations. CalRecycle Home Pageepr.sustainablepackaging.org
Market pressure: The U.S. Plastics Pact targets: 100% reusable/recyclable/compostable packaging and 30% recycled content by 2025—deadlines many firms are now sliding to 2030, but data demands remain. COAs are the primary, standardized feed for packaging material claims. U.S. Plastics PactThe Wall Street Journal
Less scrap, fewer purges: Automated COA checks (e.g., MFI ± tolerance, ash %, volatiles) before release prevent out-of-spec runs, cutting start-up scrap and purge waste.
Cleaner inventories: Systematic COA gating keeps restricted additives (e.g., PFAS, certain phthalates) out of BOMs, reducing the risk of off-spec lots entering production and later landfill.
Easier reporting: The EPA’s Toxics Release Inventory (TRI) increasingly scrutinizes plastics and additives (including PFAS). Digitized COA data streamlines annual disclosures and internal hotspot finding. In 2023, facilities reported managing ~1.56 million lbs of PFAS production-related waste—expect oversight to grow. US EPARegulations.gov
Circularity claims that stick: With <10% of U.S. plastic waste recycled, brands need defensible resin and recycled-content data to improve real outcomes (and avoid greenwashing). COA automation provides the audit trail for rPCR content and design-for-recycling choices. National Academies
Multi-format capture: Ingest supplier COAs from PDFs/portals/EDI; parse key specs (MFI, density, tensile, Vicat, additive IDs, batch/lot).
Rules & tolerance engine: Auto-validate against SOPs: grade-to-SKU mapping, tolerance bands, food-contact applicability (21 CFR section), PFAS-free attestations, colorant restrictions, recycled-content thresholds.
Supplier scorecards: Track first-pass acceptance, variance trends, late/missing COAs; trigger CAPAs.
Traceability chain: Link each finished lot back to resin lots, additive masterbatches, and their COAs for instant recall readiness.
Compliance dashboards: One-click dossiers for FDA food-contact, state PFAS packaging rules, CA SB 54 recyclability/readiness, and TRI support files. eCFRBCLPCalRecycle Home Pageepr.sustainablepackaging.orgUS EPA
Packaging (food & personal care): Enforce PFAS-free and 21 CFR 177 alignment; capture recycled-content COAs to substantiate label claims and meet retailer requirements. U.S. Food and Drug AdministrationeCFR
Medical & pharma plastics: Tighten biocompatibility inputs and lot-level test data; keep digitized trails for audits.
Automotive & durables: Standardize COA checks for thermal/mechanical specs to cut rework; map additives for DfR (design for recycling).
Resin producers & compounders: Provide machine-readable COAs (JSON/CSV) with batch analytics to reduce downstream NCRs and bolster service levels.
Star Software automates the COA lifecycle for plastics manufacturers and brand owners:
Intelligent ingestion: Reads multi-vendor COAs (scans, structured PDFs, spreadsheets) and normalizes fields like resin family, MFI, density, tensile, colorant IDs, RoHS/REACH flags.
Policy checks: Applies your FDA 21 CFR 177 mapping, PFAS-free attestations, and SB 54 recyclability logic to approve/hold lots automatically.
Traceability graph: Links raw-material COAs to WIP/FG lots for instant backward/forward tracing.
Audit & reporting: Generates binder-ready compliance packs for customers and regulators; exports data to ERP/QMS/LIMS.
In the pharmaceutical industry, precision isn’t just important—it’s non-negotiable. From batch release to regulatory inspections, every stage of production is governed by strict Good Manufacturing Practices (GMP). Among the most critical documents in this process is the Certificate of Analysis (COA)—a quality assurance report that verifies product compliance with safety and quality standards.
Yet, many pharmaceutical companies still rely on manual methods to verify COAs. While this may have sufficed in the past, today’s regulatory environment, digital compliance mandates, and sheer volume of data make manual COA verification a major liability.
Let’s break down why manual COA handling fails GMP standards—and how automation offers a future-ready solution.
COAs are often received in unstructured formats—PDFs, scanned images, or printed documents. Manually reviewing these documents introduces human error, especially when comparing dozens of parameters across lab systems and supplier data. A single oversight could mean a non-compliant batch reaches the market or a compliant one gets rejected.
Manual verification is time-consuming. QA teams often spend hours per COA cross-checking values against product specifications or material master records. This leads to bottlenecks in batch release, impacting downstream production and delivery timelines.
GMP demands clear, timestamped, and traceable documentation for all quality decisions. Paper-based or spreadsheet-driven processes lack audit trails, making it hard to demonstrate compliance during FDA or MHRA inspections.
Manual COA review processes often bypass electronic recordkeeping standards outlined under 21 CFR Part 11, which governs data integrity, authentication, and electronic signatures. Failing to comply could trigger warning letters or product holds.
At Star Software, we’ve reimagined COA verification through intelligent automation—removing manual friction while enhancing accuracy and compliance.
Our system uses AI-powered OCR to extract structured data from unstructured COAs—whether it’s a scanned PDF from a supplier or a digitally signed document. No more manual typing or value-by-value matching.
The extracted data is automatically matched with predefined quality specifications from ERP, LIMS, or MDM systems. Any out-of-spec values or missing data are instantly flagged—reducing decision latency.
Every COA processed generates a secure digital trail, complete with validation logic, user activity logs, and time-stamped approvals—ensuring you’re always audit-ready.
The platform supports electronic signatures, access control, and tamper-proof records, aligning with global regulatory requirements for data integrity and electronic documentation.
![]()
Up to 80% reduction in COA processing time
Zero data transcription errors
Audit readiness within seconds
Faster batch release and improved throughput
Better collaboration across QA, procurement, and compliance
As regulators sharpen their focus on data integrity and operational transparency, clinging to manual COA verification is no longer safe—or sustainable. Automation is more than a digital upgrade; it’s a strategic move to align your operations with GMP, accelerate compliance, and safeguard product quality.
Explore how Star Software’s COA Automation platform can future-proof your pharma operations.
Schedule a free demo
The recent slide of the U.S. dollar is stirring waves far beyond the currency markets — and the American metal industry is feeling the ripple effects. While a weaker dollar may benefit exporters by making U.S. goods more competitive abroad, the situation is far more complex. Inflationary pressures, evolving tariff policies, and compliance demands are creating a tightrope walk for manufacturers, traders, and investors.
![]()
![]()
At face value, a depreciating dollar typically boosts U.S. exports by making them more affordable for foreign buyers. This should be a tailwind for American metal producers shipping steel, aluminum, and other raw materials overseas. However, in today’s volatile economic climate, the dollar’s fall is being read as a warning signal.
As Steve Englander of Standard Chartered aptly puts it, “Having a weak dollar or a strong dollar isn’t the issue. The issue is: What is it telling you about how the world sees your policies?”
Initially buoyed by pro-growth sentiment around the Trump administration’s economic policies, the dollar peaked in early 2025. But the optimism was short-lived. Concerns over high interest rates, stubborn inflation, and aggressive tariff rhetoric spooked investors. The result? A slide in confidence toward U.S. assets, including metals.
For domestic producers, the weakening dollar presents both opportunities and challenges:
Export Boost: A cheaper dollar could increase global demand for U.S.-made steel and aluminum, especially in emerging markets.
Costlier Imports: On the flip side, metal manufacturers reliant on imported raw materials or machinery are facing higher input costs.
Tariff Uncertainty: The looming threat of new tariffs disrupts predictable trade flows, further complicating sourcing and pricing strategies.
What should be a straightforward export advantage is now a delicate balancing act. Tariff threats and global trade instability undermine long-term planning, with buyers and suppliers alike becoming more cautious.
Amid these uncertainties, regulatory compliance has emerged as a silent stabilizer for the U.S. metal industry.
Exporters must now double down on transparent documentation — including Material Test Reports (MTRs), Certificates of Origin, and Certificates of Analysis (CoAs) — to meet international trade standards and avoid costly delays or rejections.
Compliance plays three critical roles:
Risk Mitigation: In a climate of shifting tariffs and trade scrutiny, compliant documentation helps de-risk international shipments.
Trust Building: Global buyers demand traceability and accountability — accurate paperwork earns their confidence.
Automation Advantage: Companies that automate compliance workflows are staying leaner and more agile, turning what was once a back-office function into a strategic differentiator.
The weakening dollar, driven by concerns over inflation, tariffs, and investor confidence, is a wake-up call for U.S. manufacturers — especially those in the metals sector. In this uncertain environment, compliance isn’t just a legal obligation — it's a competitive weapon.
By embracing automated documentation systems and staying ahead of regulatory shifts, American metal producers can transform short-term currency volatility into long-term trade resilience.
For organizations in pharmaceuticals, chemicals, and food manufacturing, the Certificate of Analysis (CoA) is a vital document that certifies a product’s compliance with predefined quality specifications. However, when CoA processing remains manual or semi-digital, it becomes a bottleneck—delaying product release, increasing error risk, and complicating compliance.
The answer lies in CoA automation, but to unlock its full potential, it must be seamlessly integrated into your ERP (Enterprise Resource Planning) and LIMS (Laboratory Information Management System) platforms. Here’s a step-by-step guide on how to do just that.
Before jumping into the ‘how’, it’s crucial to understand the ‘why’:
Centralized Data Flow: Ensures CoA data is synchronized across procurement, quality, and production systems.
Faster Release Cycles: Real-time CoA validation speeds up batch release decisions.
Audit Readiness: Traceable, timestamped entries make regulatory audits smoother.
Supplier Collaboration: Auto-ingestion of third-party CoAs into internal systems saves time and reduces risk.
![]()
Map out how CoAs are currently received, verified, and entered into your ERP/LIMS.
Identify bottlenecks—manual data entry, missing validations, or inconsistent formats.
What are you aiming to automate—CoA intake, validation, comparison, storage, or all of the above?
Decide which systems should “talk”—ERP, LIMS, document management systems, or supplier portals.
Look for a platform that includes:
Intelligent Document Processing (IDP) with OCR & NLP
Custom validation rules (e.g., specification ranges, batch ID matching)
APIs or connectors for ERP (SAP, Oracle, NetSuite) and LIMS (LabWare, STARLIMS, etc.)
Audit trails and version control
Decide whether it will be a direct API-based integration or via middleware like Mulesoft, Boomi, or Workato.
Build mapping logic for how CoA fields will correspond to ERP/LIMS entries (e.g., batch number → material master, test results → QC module).
Set up business rules for automatic CoA validation (e.g., moisture content < 2%).
Configure exception alerts to notify quality teams for out-of-spec results.
Start with a limited group of suppliers who consistently send digital CoAs.
Run a pilot, compare output with manual processes, and refine as needed.
Provide training for QC analysts, procurement staff, and IT teams.
Monitor the adoption rate, error reduction, and efficiency gains post-integration.
All integrations must be 21 CFR Part 11 and GDPR-compliant where applicable.
Use secure data transmission protocols and implement role-based access controls.
🔴 Ignoring format diversity: Vendors send CoAs in varied formats (PDFs, scans, Word files)—ensure your tool handles all.
🔴 Not involving end-users early: QC teams must be part of design and testing phases.
🔴 Overlooking change management: Automation is not just tech—it’s a culture shift.
CoA automation is a game-changer—but it becomes truly powerful when tightly integrated with Enterprise Resource Planning (ERP) and Laboratory Information Management Systems (LIMS). With the right architecture, validation logic, and training, you can significantly reduce manual errors, accelerate batch release, and gain real-time insights across your supply chain and quality operations.
If your organization is preparing to take this leap, use the checklist above as your roadmap—and take it one integration point at a time.
In industries where quality and compliance are non-negotiable—such as pharmaceuticals, metals, and food—trust across the supply chain is paramount. One of the most critical tools in building and maintaining this trust is the Certificate of Analysis (CoA). Traditionally, these documents were manually generated and exchanged, often leading to delays, inconsistencies, and errors. But today, automation is transforming the CoA landscape, injecting speed, accuracy, and transparency into supplier-customer relationships.
A Certificate of Analysis is an authenticated document that certifies a product’s compliance with required specifications and regulatory standards. It details the composition, quality, and safety parameters of a product batch—vital information for downstream stakeholders. In pharmaceuticals, a CoA may confirm the purity and potency of an active ingredient. In the metals industry, it might verify tensile strength and composition. In food, it ensures nutritional content and absence of contaminants.
Despite their importance, CoAs have traditionally been managed through manual processes—scanned PDFs, emails, or handwritten documents. This results in several challenges:
Inconsistency in formats across suppliers makes interpretation difficult.
Human errors during data entry can jeopardize quality assurance.
Delayed documentation affects just-in-time supply chains.
Fraud risks arise from forged or altered CoAs.
In such high-stakes industries, these risks are not just operational hurdles—they can lead to regulatory non-compliance, product recalls, and loss of customer confidence.
Automated CoA systems leverage intelligent document processing (IDP), machine learning, and integrated data pipelines to generate, validate, and transmit CoAs in real time. Here's how this improves trust and transparency:
Automated systems can generate CoAs directly from quality control instruments or ERP databases, ensuring that every value reported is sourced from validated data. This traceability builds confidence among customers and regulators alike.
Using structured data templates and APIs, companies can issue CoAs in consistent digital formats across all suppliers and plants, making it easier for downstream customers to read and verify them.
By minimizing manual intervention, automation significantly reduces the scope for typographical and reporting errors—ensuring that what’s delivered is what was tested and approved.
Automated CoAs can be generated and shared instantly upon batch clearance. This accelerates shipment readiness and enhances on-time delivery metrics.
Security features like blockchain stamping or digital signatures ensure that the CoA is tamper-proof, bolstering trust in its authenticity.
With tight FDA and EMA regulations, automated CoAs ensure batch release documentation is audit-ready and available in real-time, reducing the time to market for life-saving drugs.
For steel, aluminum, and alloy manufacturers, CoAs validate material strength, composition, and tolerance. Automation improves coordination between mills and OEMs, especially in sectors like automotive and aerospace where specs are mission-critical.
From allergen declarations to microbial tests, food companies rely on CoAs for consumer safety. Automation ensures rapid response to contamination risks and transparent labeling for health-conscious consumers.
In an era of globalized supply chains and increasing demand for ESG (Environmental, Social, and Governance) transparency, automated CoAs offer more than compliance—they provide a competitive advantage. By delivering timely, accurate, and verifiable information to customers, companies can foster deeper partnerships, reduce disputes, and build brand credibility.
From the factory floor to the customer’s hands, trust must be continuously earned—and data is at the core of that trust. Automating Certificates of Analysis is not just a technological upgrade; it is a strategic imperative for businesses that aim to be transparent, agile, and accountable. As more industries adopt this approach, the supply chain itself becomes smarter, safer, and more synchronized.